BACKGROUND: Non-syndromic cleft lip and palate (CLP) is one of the most common birth defects. Recent genome-wide association studies (GWAS) have identified several novel risk loci associated with this craniofacial anomaly. Therefore, the objective of this report was to investigate the contribution of the top seven polymorphisms reaching genome-wide statistical significance in GWAS analyses in the Polish population. METHODS AND RESULTS: Nucleotide variants located at chromosomal regions 1p22.1, 10q25.3, 17q22, and 20q12 were tested in a group of 206 patients with nonsyndromic CLP and a properly matched control group. Significant results, which persisted even after Bonferroni correction (p < 0.0071), were observed for polymorphisms located at 10q25.3 (rs7078160 and rs4752028) and 17q22 (rs227731). Under a recessive model, both rs7078160 and rs4752028 were associated with a greater than fourfold increase in the risk of CLP (odds ratio [OR] = 4.536; 95% confidence interval [CI], 1.678-12.265; p = 0.0012 and OR = 4.573; 95% CI, 1.817-11.512; p = 0.0004, respectively). Polymorphism rs227731 increased the risk of CLP when analyzed under a dominant model (OR = 1.732; 95% CI, 0.184-2.253; p = 0.0044). Borderline association was alsoidentified for the 1p22.1 locus (rs481931). Moreover, 10q25.3 haplotypes were significantly associated with a susceptibility to CLP. CONCLUSION: Our evaluation study confirmed a substantial association of polymorphisms located at chromosomal regions 10q25.3 and 17q22 with nonsyndromic CLP in the Polish population.
BACKGROUND:Non-syndromic cleft lip and palate (CLP) is one of the most common birth defects. Recent genome-wide association studies (GWAS) have identified several novel risk loci associated with this craniofacial anomaly. Therefore, the objective of this report was to investigate the contribution of the top seven polymorphisms reaching genome-wide statistical significance in GWAS analyses in the Polish population. METHODS AND RESULTS: Nucleotide variants located at chromosomal regions 1p22.1, 10q25.3, 17q22, and 20q12 were tested in a group of 206 patients with nonsyndromic CLP and a properly matched control group. Significant results, which persisted even after Bonferroni correction (p < 0.0071), were observed for polymorphisms located at 10q25.3 (rs7078160 and rs4752028) and 17q22 (rs227731). Under a recessive model, both rs7078160 and rs4752028 were associated with a greater than fourfold increase in the risk of CLP (odds ratio [OR] = 4.536; 95% confidence interval [CI], 1.678-12.265; p = 0.0012 and OR = 4.573; 95% CI, 1.817-11.512; p = 0.0004, respectively). Polymorphism rs227731 increased the risk of CLP when analyzed under a dominant model (OR = 1.732; 95% CI, 0.184-2.253; p = 0.0044). Borderline association was alsoidentified for the 1p22.1 locus (rs481931). Moreover, 10q25.3 haplotypes were significantly associated with a susceptibility to CLP. CONCLUSION: Our evaluation study confirmed a substantial association of polymorphisms located at chromosomal regions 10q25.3 and 17q22 with nonsyndromic CLP in the Polish population.
Authors: Laurence J Howe; Tom G Richardson; Ryan Arathimos; Lucas Alvizi; Maria R Passos-Bueno; Philip Stanier; Ellen Nohr; Kerstin U Ludwig; Elisabeth Mangold; Michael Knapp; Evie Stergiakouli; Beate St Pourcain; George Davey Smith; Jonathan Sandy; Caroline L Relton; Sarah J Lewis; Gibran Hemani; Gemma C Sharp Journal: Epigenomics Date: 2019-01-14 Impact factor: 4.778
Authors: Alicja Zawiślak; Krzysztof Woźniak; Xabier Agirre; Satish Gupta; Beata Kawala; Anna Znamirowska-Bajowska; Katarzyna Grocholewicz; Jan Lubiński; Felipe Prosper; Anna Jakubowska Journal: Int J Environ Res Public Health Date: 2021-10-31 Impact factor: 3.390
Authors: Qianqian Chen; Hong Wang; Holger Schwender; Tianxiao Zhang; Jacqueline B Hetmanski; Yah-Huei Wu Chou; Xiaoqian Ye; Vincent Yeow; Samuel S Chong; Bo Zhang; Ethylin Wang Jabs; Margaret M Parker; Alan F Scott; Terri H Beaty Journal: PLoS One Date: 2014-10-10 Impact factor: 3.240
Authors: Hongyi Wang; Tao Qiu; Jie Shi; Jiulong Liang; Yang Wang; Liangliang Quan; Yu Zhang; Qian Zhang; Kai Tao Journal: Mol Med Rep Date: 2016-01-20 Impact factor: 2.952